Try our mobile app

Published: 2023-06-23 16:41:42 ET
<<<  go to MET company page
8-K
METLIFE INC Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F false 0001099219 0001099219 2023-06-20 2023-06-20 0001099219 us-gaap:CommonStockMember 2023-06-20 2023-06-20 0001099219 us-gaap:SeriesAPreferredStockMember 2023-06-20 2023-06-20 0001099219 us-gaap:SeriesEPreferredStockMember 2023-06-20 2023-06-20 0001099219 us-gaap:SeriesFPreferredStockMember 2023-06-20 2023-06-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 20, 2023

 

 

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

1-15787   13-4075851
(Commission
File Number)		   (IRS Employer
Identification No.)

 

200 Park Avenue, New York, NY   10166-0188
(Address of Principal Executive Offices)   (Zip Code)

(212) 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, par value $0.01   MET   New York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01   MET PRA   New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E   MET PRE   New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F   MET PRF   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

At MetLife, Inc.’s (the “Company’s”) annual meeting of common shareholders on June 20, 2023, the shareholders:

 

•  

elected fourteen Directors, each for a term expiring at the Company’s 2024 annual meeting of shareholders;

 

•  

ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2023;

 

•  

approved, on an advisory basis, the compensation paid to the Company’s Named Executive Officers as disclosed in the Company’s 2023 Proxy Statement; and

 

•  

voted, on an advisory basis, on the frequency of future advisory votes to approve the compensation paid to the Company’s Named Executive Officers (1).

Election of Directors:

 

Nominee Name

    Votes For        Votes Against        Abstained        Broker Non-Votes

Cheryl W. Grisé

      599,352,249          41,746,668          562,208        50,118,931

Carlos M. Gutierrez

      636,933,996          4,156,916          570,213        50,118,931

Carla A. Harris

      612,731,886          28,362,831          566,408        50,118,931

Gerald L. Hassell

      635,132,969          5,962,597          565,559        50,118,931

David L. Herzog

      633,890,945          7,142,691          627,489        50,118,931

R. Glenn Hubbard, Ph.D.

      613,762,698          27,323,208          575,219        50,118,931

Jeh C. Johnson

      639,521,355          1,571,626          568,144        50,118,931

Edward J. Kelly, III

      634,972,418          6,118,826          569,881        50,118,931

William E. Kennard

      639,450,751          1,629,530          580,844        50,118,931

Michel A. Khalaf

      637,285,843          3,803,700          571,582        50,118,931

Catherine R. Kinney

      626,099,466          14,978,161          583,498        50,118,931

Diana L. McKenzie

      636,408,135          4,703,203          549,787        50,118,931

Denise M. Morrison

      628,921,163          11,860,321          879,641        50,118,931

Mark A. Weinberger

      631,802,586          9,277,966          580,573        50,118,931

 

     Votes For        Votes Against        Abstained        Broker Non-Votes

Ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2023

      663,851,986          27,116,219          811,851        N/A

Advisory vote to approve the compensation paid to the Company’s Named Executive Officers

      610,139,897          29,993,247          1,527,981        50,118,931

 

     1 year      2 years      3 years      Abstained      Broker Non-Votes

Advisory vote on the frequency of future advisory votes to approve the compensation paid to the Company’s Named Executive Officers (1)

      635,251,006        506,885        5,104,805        798,430      50,118,931

 

(1)

The Company expects to disclose on Form 8-K/A its Board of Directors’ determination of the frequency with which future advisory votes on executive compensation will be held.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

METLIFE, INC.
By:  

/s/ Timothy J. Ring

Name:   Timothy J. Ring
Title:   Senior Vice President and Secretary

Date: June 23, 2023